BTK inhibition causes impaired CXCR4 signaling and reduces the PM pool of CXCR4, resulting in rapid egress of CLL cells from CXCL12-rich niches and consequently prevents re-entry of CLL cells (78, 98, 99). This evidence concerns the gene CXCL12 and B-cell chronic lymphocytic leukemia.